title: Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment.
abstract: OBJECTIVE
  To report a case of refractory atopic blepharoconjunctivitis (ABC) treated by using topical tacrolimus 0.03% dermatologic ointment.
  
  
  METHODS
  A 73-year-old man with ABC was refractory to topical corticosteroid treatment.
  
  
  RESULTS
  Topical tacrolimus 0.03% dermatologic ointment (Protopic; Astellas Pharma) was applied into the conjunctival fornix twice each day. Dramatic improvement of patient's symptoms was observed during the first week of therapy. Tacrolimus ointment treatment continued for 12 months. No drug-induced conjunctival hyperemia, ocular surface staining, or other adverse changes were noted secondary to the use of the topical tacrolimus ointment.
  
  
  CONCLUSIONS
  Topical tacrolimus 0.03% dermatologic ointment appears to be an effective treatment for ABC that is refractory to conventional therapy.
authors: Department of Ophthalmology, Konya Training and Research Hospital, Konya, Turkey. yasarsakarya@yahoo.com
authors: Yasar
authors: Y
authors: Sakarya
authors: Rabia
authors: R
authors: Sakarya
mesh_terms: D060433:Administration, Ophthalmic; D000368:Aged; D001762:Blepharitis / Q000188:drug therapy* / Q000503:physiopathology; D003233:Conjunctivitis, Allergic / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009824:Ointments; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D009824:Ointments; D016559:Tacrolimus